Health & Biotech
News
Rise and Shine: Everything you need to know before the ASX opens
Health & Biotech
Healthy balance sheet with no debt, this overlooked ASX health stock has been paying dividends for years
News
ASX Health Stocks: Botanix to get FDA approval by June; 4DMedical partners with global player, Philips
Health & Biotech
Bioxyne subsidiary unveils platform for transparent pricing in Australia’s B2B medical cannabis market
Health & Biotech
Check Up: Earnings season is almost here. Here’s how ASX biotech investors should read the 4C Report
Health & Biotech
Weed Week: Blow to cannabis as Thailand backpedals on weed law; and recent ASX pot stock winners
News
Tech Heavy: Maybe Big Tech is not what we’re cracking it up to be?
Health & Biotech
Weed Week: Cannabis stocks down almost 20% in 2023 but ECS Botanics showing resilience
News
Rise and Shine: Everything you need to know before the ASX opens
News
Closing Bell: Stocks putting out good news, sneaking in bad news while almost everyone watches the cricket
Health & Biotech
Part 1: ASX biotechs with catalysts looking to pop in 2024
Health & Biotech
Weed Week: Cannabis stocks down almost 20pc in 2023, but here’s why they could rebound by Q2 2024
Health & Biotech
Neurotech completes recruitment in Phase 2/3 autism spectrum disorder trial
Health & Biotech
Melodiol’s FY23 revenue exceeds $20m as acquisition strategy proves successful
Experts
Dr Boreham’s Crucible: Excessive sweater? Botanix is here to get you fit for public consumption again
Health & Biotech
ASX Health Stocks: Imagion and Microba’s positive Phase 1 results; and LGP’s first mover advantage in France
Health & Biotech